We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Megapixel DNA Replication Technology Promises More Sensitive Faster Diagnostics

By LabMedica International staff writers
Posted on 06 Jul 2011
A DNA measurement platform that is more sensitive and accurate for sample screening could improve a range of genetic diagnostics and screenings where precise measurement is crucial. More...
This includes the early detection of cancer, prenatal diagnostics, the analysis of single cell gene expression, and the detection of pathogens in food products.

The new digital polymerase chain reaction (PCR) device uses liquid surface tension to partition DNA samples into arrays of 1,000,000 chambers or more. This enables direct counting of single molecules isolated in individual chambers.

Digital PCR refers to a new generation of DNA replication techniques that offer increased sensitivity and density over the original technique. The greatest number of chambers available in commercially available implementations of digital PCR, using integrated microvalves, is 36,960. However, further scalability is limited by the maximum density at which valves may be reliably fabricated.

The density of reaction chambers achieved by the new platform exceeds more traditional valve-based digital PCR techniques by a factor of 100, translating directly into improved performance.

"This solves some major technical issues that have limited the scale and accuracy of traditional digital PCR techniques," says Assistant Professor Carl Hansen with the University of British Columbia (UBC; Vancouver, Canada) department of physics and astronomy and center for high-throughput biology. "It creates defect-free arrays of millions of uniform volume subreactions, and controls dehydration of these reactions during thermocycling."

Prof. Hansen believes that the digital PCR can be scaled up to hold up to approximately 10,000,000 chambers on a standard 2.54-cm (one-inch) format. The UBC scientists also found the new megapixel technique set new benchmarks in detecting rare mutations--defined as the lowest measurable ratio of two target sequences differing by a single nucleotide variation as well as new limits in the detection of subtle differences in sequence abundance. Partitioning of a one-million-chamber array takes approximately one minute.

"Our solution, or something using the same techniques, could enable a new degree of precision in measurements in biomedical research and diagnostics. The dramatic increase in assay density has important implications for the adoption of digital PCR as an economical, fast, and routine analytical tool," added Prof. Hansen.

A description of the megapixel platform was published July 3, 2011, in Nature Methods.

Related Links:

University of British Columbia



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.